Related Experiment Video
Updated: Jul 4, 2026
06:56
Development and Application of Rapamycin-regulated Tyrosine Phosphatases
Published on: September 6, 2024
Phospholipase D1 is an effector of Rheb in the mTOR pathway
1Department of Cell and Developmental Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Summary
This study reveals Phospholipase D1 (PLD1) is essential for Rheb-mediated activation of the mTOR pathway, a key target in cancer therapy. Findings uncover a novel TSC-Rheb-PLD signaling cascade, offering new therapeutic strategies.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The mammalian target of rapamycin (mTOR) pathway regulates cell growth and is a critical target for anticancer therapies.
- Upstream regulators of mTOR include the tuberous sclerosis complex (TSC1/2) proteins, the small GTPase Rheb, and Phospholipase D (PLD).
- The integration of TSC/Rheb and PLD signaling pathways within the mTOR network remains largely unexplored.
Purpose of the Study:
- To investigate the interaction and integration between the TSC/Rheb and PLD pathways in the context of mTOR signaling.
- To determine the specific role of PLD isoforms (PLD1 and PLD2) in Rheb-mediated mTOR activation.
- To elucidate the upstream regulators and downstream effectors within this newly proposed signaling cascade.
Main Methods:
- RNA interference (RNAi) to assess the requirement of PLD1 and PLD2 in Rheb-mTOR signaling.
- Overexpression and knockdown studies of Rheb and TSC2 to evaluate their impact on PLD1 activity.
- Pharmacological inhibition of AMPK and PI3K to identify upstream regulators of the TSC-Rheb-PLD pathway.
- In vitro binding assays to confirm the direct interaction between Rheb and PLD1.
Main Results:
- PLD1, but not PLD2, is required for Rheb to activate the mTOR pathway.
- Rheb overexpression activates PLD1, while Rheb knockdown impairs serum-stimulated PLD activation.
- TSC2 overexpression suppresses PLD1 activation; TSC2 loss increases basal PLD activity, supporting a TSC-Rheb-PLD cascade.
- AMPK, PI3K, and amino acid sufficiency are upstream regulators of PLD activation.
- Rheb directly binds and activates PLD1 in a GTP-dependent manner, identifying PLD1 as a Rheb effector.
Conclusions:
- Phospholipase D1 (PLD1) is a direct effector of Rheb and a crucial component of the mTOR signaling pathway.
- A novel TSC-Rheb-PLD signaling cascade is identified, integrating previously separate regulatory pathways upstream of mTOR.
- These findings provide new insights into mTOR regulation and suggest potential therapeutic targets for anticancer drug development.
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...